![logo](/logos/KDEV.ST.webp)
Karolinska Development AB (publ)
SSE:KDEV.ST
1.65 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Karolinska Development AB (publ) |
Symbool | KDEV.ST |
Munteenheid | SEK |
Prijs | 1.65 |
Beurswaarde | 441,008,230 |
Dividendpercentage | 0% |
52-weken bereik | 1.41 - 2.05 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Johan Dighed |
Website | https://www.karolinskadevelopment.com |
An error occurred while fetching data.
Over Karolinska Development AB (publ)
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)